The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the ...

With historical data showing migraine to be underdiagnosed and undertreated, new guidance from the American College of ...

Pfizer has agreed to pay $60 million to resolve allegations brought by the US government that its Biohaven Pharma subsidiary made improper payments to physicians to boost sales of its migraine drug ...

Decreased tear levels of CGRP and SP correlate with dry eye disease severity and symptoms. Study involved 12 healthy volunteers and 16 DED patients, highlighting significant neuropeptide level ...

This helps manage migraine symptoms. A 2021 systematic review and meta-analysis compared triptans, ditans, and gepants for migraine treatment. Researchers found that triptans were more effective ...

A migraine episode may have up to four distinct stages or phases, each of varying duration: prodrome, aura, headache, and postdrome. However, not everyone experiences all four stages each time ...

2024 has been a year of migraine research with a clinically relevant message: starting early anti-CGRP preventive treatment seems to be better for our patients. However, considering that migraine is ...

While both gepants and triptans bind to the blood vessel ... There are only two other such CGRP receptor antagonists: AbbVie’s Ubrogepant and Atogepant. At the start of February this year ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

CGRP antagonists, sometimes referred to as “gepants,” prevent CGRP from binding to receptors in various cell types in the brain. atogepant (Qulipta) rimegepant (Nurtec ODT) ubrogepant (Ubrelvy ...